GK Energy shares rally 7% after D-Street debut, IPO investors see 15% gains

GK Energy shares rally 7% after D-Street debut, IPO investors see 15% gains

Shares of GK Energy extended their post-listing gains on Friday, surging 6.6% to hit an intraday high of Rs 175.95 on the BSE. This fresh upmove comes after the stock listed with an 11.8% premium over its issue price of Rs 153 earlier in the day, taking total listing gains for IPO investors to nearly … Read more

SBI Card likely to benefit from festival season and GST cuts: Amnish Aggarwal

SBI Card likely to benefit from festival season and GST cuts: Amnish Aggarwal

The Indian markets are witnessing a flurry of developments across multiple sectors, with pharma, credit cards, and real estate grabbing investor attention. Pharma Sector: Event-Driven MomentumSignificant activity continues in the pharma space, with Glenmark Pharma advancing its oncology portfolio, Dr Reddy’s partnering with Hetero for an HIV prevention drug, and Lupin receiving approvals for its … Read more

Sun Pharma shares slip 3% after BofA downgrade on premium valuations

Sun Pharma shares slip 3% after BofA downgrade on premium valuations

Shares of Sun Pharmaceutical fell as much as 2.8% on Tuesday to an intraday low of Rs 1,610 on the BSE after Bank of America Securities downgraded the stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower-than-expected execution in speciality drugs. Bank of America Securities lowered its target price on Sun Pharma … Read more

FMCG in a sweet spot after GST cuts and monsoon boost: Rajat Sharma

FMCG in a sweet spot after GST cuts and monsoon boost: Rajat Sharma

“For disclosure, HUL and Asian Paints have been my top picks since the beginning of this year, and I have mentioned this on your channel before. The slowdown in consumption had been so severe that a recovery was inevitable at some point. First, we had income tax rates being revised upwards, leaving more money in … Read more

Defence stocks overheated, wait for correction: Deven Choksey

Defence stocks overheated, wait for correction: Deven Choksey

“If we look at Mahindra & Mahindra’s example, where they appointed Anisha Shah as CEO from her prior CFO role, it also proves that a transition from CFO to CEO ensures financial discipline while scaling the business. In that sense, I believe PB Balaji is a good choice and could deliver even better results going … Read more

Sun Pharma Q1 Results: Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises 10%

Sun Pharma Q1 Results: Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises 10%

Drug major Sun Pharmaceutical Industries on Thursday reported a 20% fall in its Q1 consolidated net profit to Rs 2,278 crore compared to Rs 2,836 crore in the year ago period. The company’s revenue from operation stood at Rs 13,786 crore which was up 10% versus Rs 12,525 crore posted in the corresponding quarter of … Read more

Sudip Bandyopadhyay on 2 sectors offering ‘Trump-Proof’ investment opportunities

Sudip Bandyopadhyay on 2 sectors offering ‘Trump-Proof’ investment opportunities

“Private capex, while sporadic, is seeing considerable activity in the power sector, and that’s again a big positive for capital goods companies. Taking all this into account, the space looks promising. We’ve been positive on Larsen & Toubro for a long time and continue to maintain our positive view—it’s a great stock to own if … Read more

Stay focused on domestic fundamentals; no need to react to every US macro move: Sandip Sabharwal

Stay focused on domestic fundamentals; no need to react to every US macro move: Sandip Sabharwal

“On the US tax changes and all, the only thing which should bother Indians is the remittance tax which has been proposed, which could hurt the flow of remittances to some extent and increase the cost for the Indian diaspora staying in US, so that is something which will be a small concern, ex of … Read more

Q4 results this week: ITC, Sun Pharma, IndusInd Bank, IndiGo, BEL among 81 companies set to announce earnings

Q4 results this week: ITC, Sun Pharma, IndusInd Bank, IndiGo, BEL among 81 companies set to announce earnings

India Inc’s Q4 FY25 earnings season continues this week, with 81 companies scheduled to release their financial results. Key names to watch include ITC, Sun Pharma, IndusInd Bank, Power Grid Corporation of India, Hindalco, Interglobe Aviation (IndiGo), ONGC, Bharat Electronics, DLF, Dixon Technologies, Solar Industries, United Spirits, Ashok Leyland, Grasim, RVNL, and Honasa Consumer. Here … Read more

Pharma stocks rally up to 4%, but will Trump order really have minimal impact?

Pharma stocks rally up to 4%, but will Trump order really have minimal impact?

Shares of pharmaceutical companies rallied up to 4% on Tuesday as investors expect that US President Donald Trump‘s executive order will have minimal impact on US generics. Dr Reddy’s shares were up around 4% while Granules, Glenmark, Lupin, Divi’s Lab, and Aurobindo Pharma were trading around 3% higher. Nifty Pharma index itself rose around 2% … Read more